FDA Approves Linzess to Treat Constipation in Children, Teens
WEDNESDAY, June 14, 2023 -- The U.S. Food and Drug Administration approved Linzess (linaclotide) as a once-daily treatment for pediatric patients ages 6 to 17 years with functional constipation.
The approval was based on data from 328 participants...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Children | Constipation | Food and Drug Administration (FDA) | General Medicine | Pediatrics